Research Article

Eligibility of the Systolic Blood Pressure Intervention Trial (SPRINT) to the Chinese Adults

Table 1

Overall participants meeting each sequential SPRINT eligibility criterion.

Overall participants, Overall+SBP criteria1+High CVD risk2+Exclusion Criteria3
2609314640842848134036

Socioeconomic background
 Age (years)
 Gender (male, %)10,881 (41.7%)6,201 (42.4%)3,636 (43.1%)1,555 (32.3%)1,281 (31.7%)
Educational level
 None1,698 (6.5%)1,421 (9.7%)829 (9.9%)568 (11.9%)490 (12.2%)
 Primary6,275 (24.1%)4,651 (31.9%)2,779 (33.1%)1,675 (34.9%)1,434 (35.7%)
 Secondary/high school/higher secondary14,311 (55.0%)6,602 (45.3%)3,694 (44.0%)1,890 (39.4%)1,559 (38.8%)
Trade school/college/university3,729 (14.4%)1,911 (13.1%)1,098 (13.1%)662 (13.8%)536 (13.3%)
Risk factors of hypertension
 Heart rate, beats/min
 Total cholesterol, mg/dl
 High-density lipoprotein, mg/dl
 Estimated glomerular filtration rate, ml/min/1.73 m2
 Current smoking6,254 (24.3%)3,442 (23.8%)1,896 (22.7%)1,033 (21.9%)900 (22.8%)
10,516 (40.3%)6,217 (42.5%)3,953 (46.9%)2,475 (51.4%)2,066 (51.2%)
 Framingham risk score
  <10%16,219 (63.9%)5,686 (39.9%)1,955 (23.5%)272 (5.8%)263 (6.7%)
  10%-20%5,967 (23.5%)5,435 (38.1%)4,075 (49.1%)2,143 (45.7%)1,960 (49.9%)
  >20%3,189 (12.6%)3,141 (22.0%)2,274 (27.4%)2,274 (48.5%)1,704 (43.4%)
 Physical activity
  Low3,203 (12.8%)1,673 (11.9%)1,003 (12.4%)577 (12.5%)495 (12.7%)
  Moderate10,960 (43.8%)6,280 (44.7%)3,600 (44.4%)2,127 (45.9%)1,804 (46.3%)
  High10,857 (43.4%)6,088 (43.4%)3,498 (43.2%)1,928 (41.6%)1,600 (41.0%)
Blood pressure measurement
 SBP (mmHg)
  130-139 mmHg4,607 (17.7%)2,692 (18.4%)2,692 (31.9%)1,111 (23.1%)910 (22.6%)
  ≥140 mmHg9,110 (34.9%)6,688 (45.7%)5,736 (68.1%)3,702 (76.9%)3,126 (77.4%)
 DBP (mmHg)
  80-89 mmHg8,277 (31.7%)4,812 (32.9%)3,329 (39.5%)1,754 (36.4%)1,455 (36.1%)
  ≥90 mmHg7,044 (27.0%)4,579 (31.3%)3,590 (42.6%)2,221 (46.2%)1,915 (47.5%)

Reported as or number (%). Abbreviations: CVD: cardiovascular disease. DBP: diastolic blood pressure. SBP: systolic blood pressure. SPRINT: Systolic Blood Pressure Intervention Trial. 1SBP criteria include 130-180 mmHg on 0 or 1 antihypertensive medication class; 130-170 mmHg on 2 classes; 130-160 mmHg on 3 classes; and 130-150 mmHg on 4 classes. 2High CVD risk includes history of CHD, eGFR of 20-59 ml/min/1.73 m2, 10-year risk for , and . 3Exclusion criteria include diabetes, history of stroke, and .